Topic: Top tips for completing psychotropic registers and governing medication risk in aged care.
Day: Wednesday 21 October 2020
Time: 3:30pm-4:00pm AEDT
Good clinical governance is about more than ‘just’ ticking boxes. Everything you do must positively impact the care of your residents.Good clinical governance is about more than ‘just’ ticking boxes. Everything you do must positively impact the care of your residents.In the last 12 months, the aged care industry has experienced significant momentum with respect to the governance of psychotropic medication use in aged care homes. Despite a range of tools and guidelines being available, there reigns widespread confusion on how to correctly complete psychotropic registers. There is no international consensus on what medications should be included in a chemical restraint registry and the voluminous list in the current registry adds to this confusion. In addition, governance of these high-risk medications has increased the workload burden on aged care providers in an already demanding climate.The goal of the psychotropic register is to reduce unnecessary exposure to psychotropic medications as these medications are known to cause poor health and quality of life outcomes in the older population. Counting is not enough. Good governance should also ensure that all residents exposed to these medications, where clinically appropriate, are reviewed regularly to ensure they are getting the benefits of each medication and not experiencing harm.In this presentation, we will discuss the current challenges faced by aged care providers in managing the psychotropic audit and reporting requirements of the Aged Care Safety and Quality Commission and provide evidenced-based and time saving solutions to:• Completing audit formsIdentifying appropriate vs potentially inappropriate psychotropic use• Documenting shared decision making and consents• Documenting interventions, monitoring and goals• Reporting outcomes• Ensuring at-risk residents are reviewed at clinically appropriate times• Minimising medication-related harm through documentation of the efficacy and safety of psychotropic medications for individual residents.
Natalie has a background working as a clinical pharmacist in the acute sector prior to becoming an accredited pharmacist in 2010. She is now the Head of Clinical Development for Ward Medication Management (Ward MM), leading a team of over 30 accredited clinical pharmacists. Ward MM is one of the largest providers of consultant pharmacy services in Australia. Ward MM’s goal is to eliminate medication related harm in our vulnerable older Australians. To this aim, Natalie is dedicated to improving medication management especially in the elderly by helping rationalise the prescribing of medications in this group of individuals and by educating health care professionals in this area. Natalie has recently been recognized for her work by receiving the SA Pharmacist of the Year Award 2016 and the AACP Consultant Pharmacist of the Year Award 2017. In 2019, Natalie was awarded the Advanced Pharmacist Practice credential.